De novo low-dose sirolimus versus mycophenolate mofetil in combination with extended-release tacrolimus in kidney transplant recipients: a multicentre, open-label, randomized, controlled, non-inferiority trial

Open Label ◽

Randomized Controlled

SP653COMPARISON OF LOW DOSE AND VERY LOW DOSE EXTENDED-RELEASE TACROLIMUS / MMF IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS

Nephrology Dialysis Transplantation ◽

10.1093/ndt/gfw178.12 ◽

2016 ◽

Vol 31 (suppl_1) ◽

pp. i312-i312

Author(s):

Shunji Narumi ◽

Yoshihiko Watarai ◽

Norihiko Goto ◽

Takahisa Hiramitsu ◽

Takayuki Yamamoto ◽

...

Keyword(s):

Kidney Transplant ◽

Extended Release ◽

Low Dose ◽

De Novo ◽

Transplant Recipients ◽

A randomized, open‐label pharmacokinetic trial of tacrolimus extended‐release dosing in obese de novo kidney transplant recipients

Clinical Transplantation ◽

10.1111/ctr.13640 ◽

2019 ◽

Vol 33 (8) ◽

Cited By ~ 1

Author(s):

Natalia M. Jasiak‐Panek ◽

Eric Wenzler ◽

Shree Patel ◽

James J. Thielke ◽

Kristin Progar ◽

...

Keyword(s):

Kidney Transplant ◽

Extended Release ◽

De Novo ◽

Transplant Recipients ◽

Open Label

Cyclosporine withdrawal from a mycophenolate mofetil???containing immunosuppressive regimen in stable kidney transplant recipients: a randomized, controlled study1,2

Transplantation Journal ◽

10.1097/00007890-200212270-00015 ◽

2002 ◽

pp. 1725-1734 ◽

Cited By ~ 88

Author(s):

Daniel Abramowicz ◽

Derek Manas ◽

Mieczyslaw Lao ◽

Yves Vanrenterghem ◽

Domingo del Castillo ◽

...

Keyword(s):

Mycophenolate Mofetil ◽

Kidney Transplant ◽

Immunosuppressive Regimen ◽

Transplant Recipients ◽

Randomized Controlled

Faculty Opinions recommendation of Incidence of Posttransplantation Diabetes Mellitus in De Novo Kidney Transplant Recipients Receiving Prolonged-Release Tacrolimus-Based Immunosuppression With 2 Different Corticosteroid Minimization Strategies: ADVANCE, A Randomized Controlled Trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.730161501.793556278 ◽

2019 ◽

Author(s):

Jean Francis

Keyword(s):

Diabetes Mellitus ◽

Randomized Controlled Trial ◽

Kidney Transplant ◽

De Novo ◽

Controlled Trial ◽

Prolonged Release ◽

Transplant Recipients ◽

Randomized Controlled

Mechanistic analyses in kidney transplant recipients prospectively randomized to two steroid free regimen—Low dose Tacrolimus with Everolimus versus standard dose Tacrolimus with Mycophenolate Mofetil

PLoS ONE ◽

10.1371/journal.pone.0216300 ◽

2019 ◽

Vol 14 (5) ◽

pp. e0216300 ◽

Cited By ~ 2

Author(s):

Opas Traitanon ◽

James M. Mathew ◽

Aneesha Shetty ◽

Sai Vineela Bontha ◽

Daniel G. Maluf ◽

...

Keyword(s):

Mycophenolate Mofetil ◽

Kidney Transplant ◽

Low Dose ◽

Standard Dose ◽

Transplant Recipients ◽

Novel Once-Daily Extended-Release Tacrolimus Versus Twice-Daily Tacrolimus in De Novo Kidney Transplant Recipients: Two-Year Results of Phase 3, Double-Blind, Randomized Trial

American Journal of Kidney Diseases ◽

10.1053/j.ajkd.2015.10.024 ◽

2016 ◽

Vol 67 (4) ◽

pp. 648-659 ◽

Cited By ~ 42

Author(s):

Lionel Rostaing ◽

Suphamai Bunnapradist ◽

Josep M. Grinyó ◽

Kazimierz Ciechanowski ◽

Jason E. Denny ◽

...

Keyword(s):

Randomized Trial ◽

Kidney Transplant ◽

Extended Release ◽

De Novo ◽

Transplant Recipients ◽

Phase 3 ◽

Double Blind ◽

Once Daily

Cardiovascular Risk Profile in Kidney Transplant Recipients Treated With Two Immunosuppressive Regimens: Tacrolimus and Mycophenolate Mofetil Versus Everolimus and Low-Dose Cyclosporine

Transplantation Proceedings ◽

10.1016/j.transproceed.2009.03.045 ◽

2009 ◽

Vol 41 (4) ◽

pp. 1175-1177 ◽

Cited By ~ 10

Author(s):

G. Spagnoletti ◽

F. Citterio ◽

E. Favi ◽

E. Rossi ◽

F. Delreno ◽

...

Keyword(s):

Mycophenolate Mofetil ◽

Cardiovascular Risk ◽

Kidney Transplant ◽

Low Dose ◽

Risk Profile ◽

Cardiovascular Risk Profile ◽

Transplant Recipients ◽

A 3-month, Multicenter, Randomized, Open-label Study to Evaluate the Impact on Wound Healing of the Early (vs Delayed) Introduction of Everolimus in De Novo Kidney Transplant Recipients, With a Follow-up Evaluation at 12 Months After Transplant (NEVERWOUND Study)

Transplantation Journal ◽

10.1097/tp.0000000000002851 ◽

2020 ◽

Vol 104 (2) ◽

pp. 374-386 ◽

Cited By ~ 1

Author(s):

Tommaso Maria Manzia ◽

Mario Carmellini ◽

Paola Todeschini ◽

Antonio Secchi ◽

Silvio Sandrini ◽

...

Keyword(s):

Wound Healing ◽

Kidney Transplant ◽

De Novo ◽

Transplant Recipients ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

The Impact

MP59-07 EFFICACY AND SAFETY OF EARLY EVEROLIMUS ADMINISTRATION COMBINED WITH LOW-DOSE TACROLIMUS, MYCOPHENOLATE MOFETIL, AND PREDNISOLONE IN KIDNEY TRANSPLANT RECIPIENTS

The Journal of Urology ◽

10.1097/ju.0000000000000928.07 ◽

2020 ◽

Vol 203 ◽

pp. e882-e883

Author(s):

Ryohei Yamamoto* ◽

Mituru Saito ◽

Ryuichiro Sagehashi ◽

Taketoshi Nara ◽

Sohei Kanda ◽

...

Keyword(s):

Mycophenolate Mofetil ◽

Kidney Transplant ◽

Low Dose ◽

Efficacy And Safety ◽

Transplant Recipients ◽

Pharmacokinetics of Prolonged-Release Once-Daily Formulations of Tacrolimus in De Novo Kidney Transplant Recipients: A Randomized, Parallel-Group, Open-Label, Multicenter Study

Advances in Therapy ◽

10.1007/s12325-018-0855-1 ◽

2018 ◽

Vol 36 (2) ◽

pp. 462-477 ◽

Cited By ~ 4

Author(s):

Nassim Kamar ◽

Elisabeth Cassuto ◽

Giovanni Piotti ◽

Mirco Govoni ◽

Giorgia Ciurlia ◽

...

Keyword(s):

Kidney Transplant ◽

Multicenter Study ◽

De Novo ◽

Prolonged Release ◽

Transplant Recipients ◽

Open Label ◽

Once Daily ◽

Parallel Group